Adrelia Allen is the Executive Director of Clinical Trial Patient Diversity at Merck, where she spearheads initiatives to enhance diversity in clinical trials. Her work focuses on increasing representation from communities historically underrepresented in research, aligning with Merck's strategic goals in healthcare innovation.
With over two decades of experience, Allen is a seasoned professional in clinical trial operations, strategic planning, and advocacy within the healthcare industry.